GALAPAGOS NV's ticker is GLPG and the CUSIP is 36315X101. A total of 74 filers reported holding GALAPAGOS NV in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $118,000 | -13.9% | 600 | -14.3% | 0.03% | -52.9% |
Q1 2020 | $137,000 | +813.3% | 700 | +600.0% | 0.07% | +1650.0% |
Q3 2019 | $15,000 | -81.2% | 100 | -87.5% | 0.00% | -80.0% |
Q1 2018 | $80,000 | +321.1% | 800 | +300.0% | 0.02% | +400.0% |
Q4 2017 | $19,000 | -88.7% | 200 | -90.9% | 0.00% | -84.0% |
Q2 2017 | $168,000 | – | 2,200 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 250,680 | $13,188,000 | 7.26% |
Stonepine Capital Management, LLC | 244,205 | $12,848,000 | 5.85% |
Sio Capital Management, LLC | 224,719 | $11,822,000 | 3.77% |
EcoR1 Capital, LLC | 1,558,749 | $82,006,000 | 2.85% |
BVF INC/IL | 1,119,733 | $58,909,000 | 2.30% |
683 Capital Management, LLC | 701,421 | $36,902,000 | 1.44% |
DAFNA Capital Management LLC | 77,675 | $4,086,000 | 1.08% |
Soleus Capital Management, L.P. | 115,300 | $6,066,000 | 0.94% |
APOGEM CAPITAL LLC | 19,267 | $1,014,000 | 0.64% |
Orbimed Advisors | 723,457 | $38,061,000 | 0.42% |